Literature DB >> 14675042

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

Fiona Chow1, Elyce Ozols, David J Nikolic-Paterson, Robert C Atkins, Gregory H Tesch.   

Abstract

BACKGROUND: Macrophage-mediated renal injury has been implicated in progressive forms of glomerulonephritis; however, a role for macrophages in type 2 diabetic nephropathy, the major cause of end-stage renal failure, has not been established. Therefore, we examined whether macrophages may promote the progression of type 2 diabetic nephropathy in db/db mice.
METHODS: The incidence of renal injury was examined in db/db mice with varying blood sugar and lipid levels at 8 months of age. The association of renal injury with the accumulation of kidney macrophages was analyzed in normal db/+ and diabetic db/db mice at 2, 4, 6, and 8 months of age.
RESULTS: In db/db mice, albuminuria and increased plasma creatinine correlated with elevated blood glucose and hemoglobin A1c (HbA1c) levels but not with obesity or hyperlipidemia. Progressive diabetic nephropathy in db/db mice was associated with increased kidney macrophages. Macrophage accumulation and macrophage activation in db/db mice correlated with hyperglycemia, HbA1c levels, albuminuria, elevated plasma creatinine, glomerular and tubular damage, renal fibrosis, and kidney expression of macrophage chemokines [monocyte chemoattractant protein-1 (MCP-1), osteopontin, migration inhibitory factor (MIF), monocyte-colony-stimulating factor (M-CSF)]. The accrual and activation of glomerular macrophages also correlated with increased glomerular IgG and C3 deposition, which was itself dependent on hyperglycemia.
CONCLUSION: Kidney macrophage accumulation is associated with the progression of type 2 diabetic nephropathy in db/db mice. Macrophage accumulation and activation in diabetic db/db kidneys is associated with prolonged hyperglycemia, glomerular immune complex deposition, and increased kidney chemokine production, and raises the possibility of specific therapies for targeting macrophage-mediated injury in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675042     DOI: 10.1111/j.1523-1755.2004.00367.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  176 in total

1.  Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

Authors:  Tomohito Gohda; William H Walker; Pawel Wolkow; Jung Eun Lee; James H Warram; Andrzej S Krolewski; Monika A Niewczas
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

2.  Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients.

Authors:  Atsuhito Tone; Kenichi Shikata; Koichi Nakagawa; Masaaki Hashimoto; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

3.  Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis.

Authors:  Jameel Dennis; Daniel T Meehan; Duane Delimont; Marisa Zallocchi; Greg A Perry; Stacie O'Brien; Hongmin Tu; Taina Pihlajaniemi; Dominic Cosgrove
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

4.  Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction.

Authors:  David J Nikolic-Paterson
Journal:  J Am Soc Nephrol       Date:  2015-11-20       Impact factor: 10.121

Review 5.  Inflammation and diabetic nephropathy.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

6.  Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo.

Authors:  Heather M Wilson; Salah Chettibi; Christian Jobin; David Walbaum; Andrew J Rees; David C Kluth
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 7.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

8.  PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.

Authors:  Jin-Xia Zhai; Zhao-Xiang Zhang; Ya-Juan Feng; Shu-Shu Ding; Xing-Hua Wang; Li-Wei Zou; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

9.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.